CPA
IRMD icon

Capital Performance Advisors’s iRadimed IRMD Stock Holding History

Capital Performance Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25
Closed -$1.26K – 1386
2024
Q3 		$1.26K Buy
+25
New +$1.15K ﹤0.01% 1793

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Performance Advisors's IRMD Position: Q4 2024 in Review

Capital Performance Advisors sold out of iRadimed (IRMD) in Q4 2024, closing a stake of 25 shares — an estimated $1.26K sold.

Capital Performance Advisors first reported a position in IRMD in Q3 2024 and held it in 1 quarter. The position peaked at $1.26K in Q3 2024. 166 funds tracked by Wall St. Rank hold IRMD as of Q4 2024.

  • Capital Performance Advisors reported no remaining iRadimed position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 25 iRadimed shares in Q4 2024, an estimated $1.26K.
  • Capital Performance Advisors first reported a position in iRadimed in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's iRadimed position peaked at $1.26K in Q3 2024.
  • 166 funds tracked by Wall St. Rank held iRadimed as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.